Marc Better
Impact in
-
- Monoclonal and Polyclonal Antibodies Research
- Biotechnology top 2%
- Transgenic Plants and Applications
Papers in
- Immunology 16
- Toxin Mechanisms and Immunotoxins 11
- Biosimilars and Bioanalytical Methods 4
-
- RNA and protein synthesis mechanisms 6
- Glycosylation and Glycoproteins Research 3
- Co-authors
- Arnold H. Horwitz (7 shared papers)Chun‐Wei Chang (3 shared papers)Randy Robinson (2 shared papers)Donald R. Helinski (3 shared papers)Gary S. Ditta (2 shared papers)Harrison Echols (3 shared papers)Adrian Bot (7 shared papers)Barbara Lewis (1 shared paper)
- Journals
- Proceedings of the National Academy of Sciences (4 papers)Journal of Biological Chemistry (3 papers)Journal of Clinical Oncology (2 papers)Cell (2 papers)Cancer Research (2 papers)
- Partner nations
- United StatesAustraliaCzechia
In The Last Decade
Marc Better
37 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 84
- Radiology, Nuclear Medicine and Imaging 629
- Biotechnology 211
- Immunology 481
- Oncology 522
- Molecular Biology 1.1k
Countries citing papers authored by Marc Better
This map shows the geographic impact of Marc Better's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Better with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Better more than expected).
Fields of papers citing papers by Marc Better
This network shows the impact of papers produced by Marc Better. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Better. The network helps show where Marc Better may publish in the future.
Co-authors
The 25 scholars most cited alongside Marc Better, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1988 | 441 | |
| 2 | 2020 | 282 | |
| 3 | 1991 | 210 | |
| 4 | 1983 | 145 | |
| 5 | 1988 | 126 | |
| 6 | 1982 | 112 | |
| 7 | 1983 | 105 | |
| 8 | 2017 | 87 | |
| 9 | 1985 | 73 | |
| 10 | 1983 | 66 | |
| 11 | 1983 | 40 | |
| 12 | 1994 | 40 | |
| 13 | 1993 | 39 | |
| 14 | 2016 | 38 | |
| 15 | 1992 | 31 | |
| 16 | 1993 | 28 | |
| 17 | 1985 | 26 | |
| 18 | 1994 | 23 | |
| 19 | 1992 | 20 | |
| 20 | 1984 | 18 |
About Marc Better
Marc Better is a scholar working on Immunology, Molecular Biology, Oncology, Radiology, Nuclear Medicine and Imaging and Biotechnology, having authored 37 papers that have together received 2.1k indexed citations. Recurring topics across this work include CAR-T cell therapy research (11 papers), Toxin Mechanisms and Immunotoxins (11 papers), Monoclonal and Polyclonal Antibodies Research (10 papers), Transgenic Plants and Applications (8 papers), Bacteriophages and microbial interactions (7 papers), RNA and protein synthesis mechanisms (6 papers), Biosimilars and Bioanalytical Methods (4 papers) and Glycosylation and Glycoproteins Research (3 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (629 citations), Biotechnology (211 citations), Immunology (481 citations), Oncology (522 citations) and Molecular Biology (1.1k citations). Marc Better has collaborated with scholars based in United States, Australia and Czechia. Frequent co-authors include Arnold H. Horwitz, Chun‐Wei Chang, Randy Robinson, Donald R. Helinski, Gary S. Ditta, Harrison Echols, Adrian Bot, Barbara Lewis, Robley C. Williams and Charles Lu. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry, Journal of Clinical Oncology, Cell and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.